Source: Health Products and Food Branch (CA) Revision Year: 2014
NOCDURNA.
| Route of Administration | Dosage Form / Strength | Clinically Relevant Non medicinal Ingredients |
|---|---|---|
| Sublingual | Orally Disintegrating Tablets Female: 25 µg Male: 50µg | Gelatin, Mannitol, Citric Acid |
NOCDURNA is an orally disintegrating tablet containing desmopressin acetate equivalent to 25 or 50 µg of desmopressin as free base. The inactive ingredients are gelatin, mannitol, and anhydrous citric acid.
NOCDURNA 25 µg is a white, round, orally disintegrating tablet with “25” on one side.
NOCDURNA 50 µg is a white, round, orally disintegrating tablet with “50” on one side.
NOCDURNA Initiation Pack for Men >65 Years of Age is packaged as a unit dose blister (4 units per box)
NOCDURNA is packaged as a unit dose blister, 10 units per blister pack, 3 blister packs (30 unit doses) per box.
| Marketing Informations | Authorization Dates |
|---|---|
|
Authorization holder:
Ferring Inc., 200 Yorkland Boulevard, Suite 500, North York, Ontario, M2J 5C1 168240 |
Date of revision:
September 3, 2014 |
| Drug | Countries | |
|---|---|---|
| NOCDURNA | Canada, Finland, Hong Kong, Israel, Netherlands, Romania, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
